Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187498 · ClinicalTrials.gov registry record · Phase 3
Behavioral Treatment of Overactive Bladder in Men
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 143
- Enrollment target
NCT01187498 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 143 participants.
The verdict
NCT01187498, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 143 participants
- Enrollment target
Study Summary
The primary purpose of this project is to evaluate the effectiveness of behavioral treatment compared to standard drug therapy for symptoms of OAB in male veterans.
Interventions
- BEHAVIORAL Behavioral training
- DRUG Oxybutynin chloride, extended-release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01187498
The ClinicalTrials.gov registry entry for NCT01187498 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral training is the first listed.
NCT01187498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01187498 about?
NCT01187498 is a clinical study titled "Behavioral Treatment of Overactive Bladder in Men". The primary purpose of this project is to evaluate the effectiveness of behavioral treatment compared to standard drug therapy for symptoms of OAB in male veterans.
What is the current status of trial NCT01187498?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 143 participants. The study started on 2005-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT01187498?
The interventions under investigation include: Behavioral training (BEHAVIORAL), Oxybutynin chloride, extended-release (DRUG).
Who is sponsoring clinical trial NCT01187498?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.